Chapter 209

2019 -- S 0223 Enacted 07/15/2019

A N   A C T

RELATING TO HEALTH AND SAFETY -- ESTABLISHING A PROGRAM WITHIN THE DEPARTMENT OF HEALTH TO ADDRESS ALZHEIMER'S DISEASE

Introduced By: Senators Coyne, Lynch Prata, Miller, McCaffrey, and Satchell

Date Introduced: January 31, 2019

It is enacted by the General Assembly as follows:

SECTION 1. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby

amended by adding thereto the following chapter:

CHAPTER 1.7

THE RHODE ISLAND PROGRAM TO ADDRESS ALZHEIMER'S DISEASE

23-1.7-1. Duties -- Director of the department of health.

The director of the department of health shall develop and carry out an assessment of all

state programs that address Alzheimer's disease and shall maintain and annually update the Rhode

Island state plan for Alzheimer's disease and related disorders, and promulgate rules and

regulations to implement the purpose of this chapter.

23-1.7-2. Creation of advisory council.

(a) There is hereby established a council to be called the "Advisory Council on

Alzheimer's Disease Research and Treatment." The advisory council shall consist of thirteen (13)

members to be composed as follows: the lieutenant governor, or designee; the director of the

department of health, or designee; the director of the division of elderly affairs office of healthy

aging, or designee; the chairperson of the long-term care coordinating council; one member

appointed by the speaker of the house; one member appointed by the president of the senate; and

seven (7) members appointed by the governor. The members appointed by the governor shall

include one member who is an Alzheimer's disease patient advocate; one member who is an

Alzheimer's disease caregiver; one member who is a health care healthcare provider; one

member who is a researcher with Alzheimer's-related expertise in basic, translational, clinical, or

drug-development science; one member who is a representative from an Alzheimer's disease

organization that funds research and has demonstrated experience in care and patient services;

one member from an Alzheimer's advocacy organization that provides services to families and

professionals, including information and referrals, support groups, care consultation, education,

and safety services; and one member who is a representative of a health care healthcare insurer.

Advisory council members shall select their own chairperson. Seven (7) members shall constitute

a quorum.

(b) The member appointed by the speaker of the house, the member appointed by the

president of the senate, and three (3) members appointed by the governor shall be initially

appointed for a term to expire July 1, 2020, and four (4) members to be appointed by the governor

shall be initially appointed for a term to expire July 1, 2021. After the initial term, the appointed

members shall serve two-(2) year (2) terms, until their successor is appointed.

23-1.7-3. Advisory council responsibility.

(a) The advisory council shall meet at least quarterly and shall advise the governor,

speaker of the house, and president of the senate on developments and advances on the diagnosis,

treatment, and prevention of Alzheimer's disease.

(b) In coordination with the department of health, the advisory council shall determine

the number of residents diagnosed with Alzheimer's disease to ascertain the number of residents

diagnosed with early-onset Alzheimer's disease, regardless of age.

(c) The advisory council shall identify available resources and services needed for the

treatment and care of residents diagnosed with Alzheimer's disease.

(d) Annually, not later than March 1, the advisory council shall provide a report to the

director of the department of health with a copy to the governor, the speaker of the house, and the

president of the senate, which shall include:

(1) Information and recommendations on Alzheimer's disease policy;

(2) An evaluation of all state-funded efforts in Alzheimer's disease research, clinical care,

institutional, home-based, and community-based programs; and

(3) Recommended amendments, updates, and changes to the state plan for Alzheimer's

disease and related disorders.

23-1.7-4. Assessment protocol.

(a) The director of the department of health shall establish and publish an Alzheimer's

disease assessment protocol specifically focused on recognizing the signs and symptoms of

cognitive impairments, including, but not limited to, Alzheimer's disease and appropriate resource

information for effective medical screening, investigation, and service planning.

(b) The director of the department of health shall make available upon request a copy of

the assessment protocol to protective-services caseworkers, health care healthcare professionals,

and members of the public.

(c) Protective-services caseworkers assigned to or employed by the department of elderly

affairs office on healthy aging shall be familiar with the information contained in the assessment

protocol.

23-1.7-5. Medical professional training.

(a) All physicians licensed pursuant to chapter 37 of title 5, and nurses licensed pursuant

to chapter 34 of title 5, shall, no later than October 1, 2021, complete a one-time course of

training consisting of a minimum of one hour of instruction on the diagnosis, treatment, and care

of patients with cognitive impairments including, but not limited to, Alzheimer's disease and

dementia.

(b) The department of health shall promulgate rules to implement the training

requirement of subsection (a) of this section.

23-1.7-6. Health care Healthcare facility plan.

(a) Every health care healthcare facility as defined in § 23-7-2 23-17-2 shall, not later

than October 1, 2021, complete and implement an operational plan for the recognition and

management of patients with Alzheimer's disease or dementia.

(b) The department of health shall promulgate rules and regulations to implement the

operational plan requirements of subsection (a) of this section.

SECTION 2. This act shall take effect upon passage.

========

LC001120

========